Publisher: John Wiley & Sons Inc
E-ISSN: 1532-6535|94|1|142-149
ISSN: 0009-9236
Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.1, 2013-07, pp. : 142-149
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost‐effectiveness of screening for HLA‐A*31:01 prior to initiation of carbamazepine in epilepsy
EPILEPSIA, Vol. 56, Iss. 4, 2015-04 ,pp. :
HLA-B*5701 screening for hypersensitivity to abacavir
By Faruki Hawazin Lai-Goldman Myla
Personalized Medicine, Vol. 5, Iss. 3, 2008-05 ,pp. :
HLA Allelic Variants and Carbamazepine‐Induced Hypersensitivity
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 5, 2013-05 ,pp. :
A novel
HLA, Vol. 87, Iss. 2, 2016-02 ,pp. :